|
Market Cap (22-Jun) $292,012,800 (943rd) |
Close (30-Jun) $0.350 |
Volume (30-Jun) 313,271 |
Shortsold (6-Jun) 238,849 (0.10%) (425th) |
|
52w High $1.79 |
52w Low $0.350 |
P/E - |
EPS -0.02 |
OCC released this announcement to the ASX on 27 August 2021, 18:38. The announcement is marked as price sensitive, and is 66 page(s) in length and 4.28MB in size.
You can view all announcements from OCC and see how they appear on a price chart on the announcements page.
At the date of this announcement, OCC was 0.107% short sold according to ASIC data. It was ranked the 440th most shorted stock on the ASX. It is now ranked as the 425th most shorted stock on the ASX with 0.099% of total shares short sold as of the latest reported data (06 June 2025).
| Other Recent Announcements from OCC | |
|---|---|
| Orthocell receives A$3.17m R&D tax incentive refund | 21 June 2023, 9:00 |
| Change of Director's Interest Notice - Paul Anderson | 16 June 2023, 9:08 |
| Change of Director's Interest Notice - Paul Anderson | 13 June 2023, 9:25 |
| Appendix 4E and Annual Report to Shareholders | 27 August 2021, 18:38 |
| Appendix 4G | 27 August 2021, 18:33 |
| Annual General Meeting | 27 August 2021, 18:30 |
| CelGro Nerve Study Results Presented at AOA annual Meeting | 23 August 2021, 9:26 |
You must be logged in to post a reply.
Orthocell 